DALLAS--(BUSINESS WIRE)--HemoBioTech, Inc. (OTCBB: HMB) (www.hemobiotech.com) announced today that Dr. Arthur P. Bollon, its Chairman & CEO, will make a company presentation at the Rodman & Renshaw 10th Annual Healthcare Conference on November 12, at 12 noon. The meeting will be held at The New York Palace Hotel in New York City. The conference is a leading health care conference involving venture capital and investment banking firms and analysts specializing in health care. Dr. Bollon will review the strategy of HemoBioTech for commercialization of its HemoTech and ORTH technologies.
